Table 2B.
Structural abnormalities: Intermethod agreement between Original MRI and AFSMRI
| Intermethod Agreement | ||||||
|---|---|---|---|---|---|---|
| Reader 1 | Reader 2 | Reader 3 | ||||
| Structure | P value* | kappa values** | P value* | kappa values** | P value* | kappa values** |
| Menisci | 0.5 | 0.76(0.66–0.85) | 0.8 | 0.71(0.6–0.83) | 0.1 | 0.57(0.45–0.69) |
| Cruciate Ligaments | 0.7 | 0.84(0.69–0.99) | 0.2 | 0.69(0.48–0.9) | 0.9 | 0.44(0.24–0.64) |
| Collateral Ligaments | 0.5 | 0.87(0.75–0.99) | 0.2 | 0.58(0.38–0.78) | 0.4 | 0.18(−0.02–0.39) |
| Tendons (quadriceps / patellar) | 0.8 | 0.94(0.83–1) | 0.003 | 0.16(−0.34–0.66) | 0.1 | 0.16(−0.14–0.46) |
| Cartilage (femur, tibia, and patella)† | 0.4 | 0.35(0.17–0.51) | 0.6 | 0.25(0.1–0.4) | 0.02 | 0.28(0.16–0.4) |
| Bone marrow abnormalities (edema and fracture) | 0.6 | 0.62 (0.55–0.7) | 0.6 | 0.59(0.51–0.67) | 0.4 | 0.4(0.3–0.51) |
Wilcoxon Rank test;
Cohen’s kappa values, with 95% confidence intervals in parentheses;
Data were dichotomized into defect (partial and full thickness) and no-defect (normal) groups.